Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2023.
The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting in 2017, consists of:
- Patrick Sobocki, appointed by Stiftelsen Industrifonden
- Karl Tobieson, appointed by Linc AB
- Jan Särlvik, appointed by Fjärde AP-fonden
- Elmar Schnee (chairman of the board of directors)
The nomination committee shall, before the annual general meeting 2023, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto.
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting on May 25, 2023, can do so by e-mail to finance@calliditas.com. Proposals should be submitted to the nomination committee before March 29, 2023.